275 related articles for article (PubMed ID: 15127235)
1. Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?
Tarazona R; Casado JG; Soto R; DelaRosa O; Peralbo E; Rioja L; Peña J; Solana R
Cancer Immunol Immunother; 2004 Oct; 53(10):911-24. PubMed ID: 15127235
[TBL] [Abstract][Full Text] [Related]
2. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype.
Casado JG; Soto R; DelaRosa O; Peralbo E; del Carmen Muñoz-Villanueva M; Rioja L; Peña J; Solana R; Tarazona R
Cancer Immunol Immunother; 2005 Dec; 54(12):1162-71. PubMed ID: 15889254
[TBL] [Abstract][Full Text] [Related]
3. The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia.
Matsumoto K; Anasetti C
Leuk Lymphoma; 1999 Nov; 35(5-6):427-35. PubMed ID: 10609780
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands.
Solana R; Casado JG; Delgado E; DelaRosa O; Marín J; Durán E; Pawelec G; Tarazona R
Cancer Immunol Immunother; 2007 Jan; 56(1):101-9. PubMed ID: 16485126
[TBL] [Abstract][Full Text] [Related]
5. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy.
Seko Y; Takahashi N; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Suzuki S; Ishiwata S; Kawai S; Azuma M; Yagita H; Okumura K; Yazaki Y
Circulation; 1998 Feb; 97(7):637-9. PubMed ID: 9495297
[TBL] [Abstract][Full Text] [Related]
7. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
[TBL] [Abstract][Full Text] [Related]
8. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
10. Expression of MHC Class II and B7-1 and B7-2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cells.
Ostrand-Rosenberg S; Baskar S; Patterson N; Clements VK
Tissue Antigens; 1996 May; 47(5):414-21. PubMed ID: 8795142
[TBL] [Abstract][Full Text] [Related]
11. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
Speiser DE; Pittet MJ; Valmori D; Dunbar R; Rimoldi D; Liénard D; MacDonald HR; Cerottini JC; Cerundolo V; Romero P
J Exp Med; 1999 Sep; 190(6):775-82. PubMed ID: 10499916
[TBL] [Abstract][Full Text] [Related]
12. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
14. From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas.
Chaperot L; Jacob MC; Molens JP; Manches O; Bensa JC; Plumas J
Leuk Lymphoma; 2000 Jul; 38(3-4):247-63. PubMed ID: 10830732
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells.
Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM
Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
Derre L; Corvaisier M; Pandolfino MC; Diez E; Jotereau F; Gervois N
J Immunol; 2002 May; 168(10):4864-70. PubMed ID: 11994435
[TBL] [Abstract][Full Text] [Related]
17. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
Viret C; Gervois N; Guilloux Y; Le Dréan E; Diez E; Jotereau F
Int Immunol; 1995 Oct; 7(10):1535-43. PubMed ID: 8562498
[TBL] [Abstract][Full Text] [Related]
18. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity.
Noppen C; Schaefer C; Zajac P; Schütz A; Kocher T; Kloth J; Heberer M; Colonna M; De Libero G; Spagnoli GC
Eur J Immunol; 1998 Apr; 28(4):1134-42. PubMed ID: 9565352
[TBL] [Abstract][Full Text] [Related]
19. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
[TBL] [Abstract][Full Text] [Related]
20. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]